Healthtech platform, Medikabazaar, declared that it had raised $75 million in its Series C funding led by Creagis and CDC Group. The existing investors, including Ackermans & van Haaren (AvH), HealthQuad Advisors Private Limited, Rebright Partners, Kois Holdings, and Sumitomo Mitsui Financial Group, also participated in the round. The funds will deepen the company’s digital capabilities, grow the supply ecosystem, technology-driven distribution channels and provide a more extensive range of quality medical supplies over geographical regions.

• Is your trading account keeping up with what markets demand in 2026?
• Texmaco Rail Surges 15% on Rs 4,045 Cr South African Rail Order
• RVNL Shares Gain 2% on Securing Rs 221 Crore Order 
• Tata Power Slides 3.85% as Q4 Profit Drops, Revenue Misses
• Stocks Under F&O Ban: Steel Authority of India

“We are thrilled to welcome Creagis and the CDC Group on board as investors. We are fascinated by the digital transformation track record of Creaegis and are trying to create a technology-driven platform assisting the healthcare ecosystem. The investment will let us improve our international operations and strengthen our presence in the B2B health tech industry,” Vivek Tiwari, Founder and Chief Executive Officer of Medikabazaar said. “With over 100,000 medical institutions, above 150,000 medical professionals, and over 15,000 seller partners, we are trying for a 300 per cent growth in FY22,” Tiwari added.